Charles de la Personne
Charles de la Personne has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Dubroc
Di&Care, Loos, France
3 shared publications - Emilie Stern
Université Paris Cité, Laboratoire de Psychopathologie et Processus de Santé, F-92100, Boulogne-Billancourt, France; Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, 1 rue Cabanis, 75014 Paris, France
3 shared publications - Pierre Alexis Geoffroy
Inserm U1141, Université de Paris, NeuroDiderot Paris France
3 shared publications - Stéphane Mouchabac
Department of Psychiatry, Saint-Antoine Hospital, DMU neurosciences, AP-HP, Sorbonne université, Paris, France; ICRIN Psychiatry, Paris Brain Institute (ICM), Inserm, CNRS, Sorbonne université, Paris, France
3 shared publications - Severine Brune
Centre de l'insomnie PsySomnie, Toulouse, France
2 shared publications - Julia Maruani
Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat–Claude Bernard , Paris F-75018
1 shared publication
Latest Publications
- Open Access
- 22 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Online Recruitment for Psychometric Research and Development of the Comprehensive Report of Insomnia Symptoms (CRIS) a digital PROM : Sequential Psychometric Validation Study (Preprint)
BACKGROUND PROMs are important in insomnia, where diagnosis and treatment outcomes rely on patients’ subjective experience of sleep difficulties and daytime consequences. The 10-item Comprehensive Report of Insomnia Symptoms (CRIS) was developed as a brief digital PROM to capture these dimensions. OBJECTIVE To evaluate the structural and external validity, responsiveness, and score interpretation of the CRIS and the feasibility of a sequential psychometric validation strategy based on open online recruitment. METHODS The CRIS was developed through a literature review, multidisciplinary expert consultation, and two rounds of cognitive interviews. Structural validation used a sequential two-wave design, with confirmatory factor analysis in an initial online sample (N=568), followed by item revision and independent validation of the modified model (N=457), including measurement invariance across sex and age. External validation against the ISI was conducted in a separate clinical sample (N=115 at baseline; N=61 at Week 4), assessing convergent and known-groups validity, responsiveness, and exploratory ISI-anchored score ranges. RESULTS In the first wave, Q2 and Q8 showed the weakest factor loadings and helped guide revision of the scale. In Wave 2, standardized loadings ranged from 0.436 to 0.834 and the two factors were moderately correlated (r=0.525). Fit of the prespecified model was mixed (CFI=0.924, TLI=0.900, SRMR=0.0588, RMSEA=0.0943), whereas a post hoc sensitivity model allowing residual covariance between Q3 and Q5 showed improved fit (CFI=0.964, TLI=0.951, SRMR=0.0462, RMSEA=0.0659). Metric invariance across sex and age groups was supported in sensitivity analyses. CRIS scores correlated with ISI scores at baseline (r=−0.34), with a stronger association at Week 4 (r=−0.66). CRIS scores varied systematically across predefined ISI strata, supporting convergent and known-groups validity. Among participants with longitudinal data, changes in CRIS and ISI scores were correlated. Exploratory ROC analyses identified four descriptive CRIS score ranges (≥67, 45–66, 17–44, and ≤16), with 66.5% exact agreement and 98.9% agreement within the same or an adjacent ISI category. An increase of approximately 24 points in the CRIS score showed 77% sensitivity and 77% specificity for correspondence with an improvement of at least 7 points on the ISI (AUC=0.79). CONCLUSIONS The CRIS is a brief digital PROM with a coherent two-factor structure, evidence of convergent validity, and evidence of responsiveness to patient-reported change. Sequential evaluation in two independently recruited online samples, together with metric invariance across sex and age, supports the feasibility of structured psychometric validation using this type of recruitment. Its brief visual-analogue format and suitability for repeated administration make the CRIS particularly relevant to digital clinical settings, including longitudinal monitoring during CBT-I and digital CBT-I.
- 22 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessOnline Recruitment for Psychometric Research and Development of the Comprehensive Report of Insomnia Symptoms (CRIS) a digital PROM : Sequential Psychometric Validation Study (Preprint)
BACKGROUND PROMs are important in insomnia, where diagnosis and treatment outcomes rely on patients’ subjective experience of sleep difficulties and daytime consequences. The 10-item Comprehensive Report of Insomnia Symptoms (CRIS) was developed as a brief digital PROM to capture these dimensions. OBJECTIVE To evaluate the structural and external validity, responsiveness, and score interpretation of the CRIS and the feasibility of a sequential psychometric validation strategy based on open online recruitment. METHODS The CRIS was developed through a literature review, multidisciplinary expert consultation, and two rounds of cognitive interviews. Structural validation used a sequential two-wave design, with confirmatory factor analysis in an initial online sample (N=568), followed by item revision and independent validation of the modified model (N=457), including measurement invariance across sex and age. External validation against the ISI was conducted in a separate clinical sample (N=115 at baseline; N=61 at Week 4), assessing convergent and known-groups validity, responsiveness, and exploratory ISI-anchored score ranges. RESULTS In the first wave, Q2 and Q8 showed the weakest factor loadings and helped guide revision of the scale. In Wave 2, standardized loadings ranged from 0.436 to 0.834 and the two factors were moderately correlated (r=0.525). Fit of the prespecified model was mixed (CFI=0.924, TLI=0.900, SRMR=0.0588, RMSEA=0.0943), whereas a post hoc sensitivity model allowing residual covariance between Q3 and Q5 showed improved fit (CFI=0.964, TLI=0.951, SRMR=0.0462, RMSEA=0.0659). Metric invariance across sex and age groups was supported in sensitivity analyses. CRIS scores correlated with ISI scores at baseline (r=−0.34), with a stronger association at Week 4 (r=−0.66). CRIS scores varied systematically across predefined ISI strata, supporting convergent and known-groups validity. Among participants with longitudinal data, changes in CRIS and ISI scores were correlated. Exploratory ROC analyses identified four descriptive CRIS score ranges (≥67, 45–66, 17–44, and ≤16), with 66.5% exact agreement and 98.9% agreement within the same or an adjacent ISI category. An increase of approximately 24 points in the CRIS score showed 77% sensitivity and 77% specificity for correspondence with an improvement of at least 7 points on the ISI (AUC=0.79). CONCLUSIONS The CRIS is a brief digital PROM with a coherent two-factor structure, evidence of convergent validity, and evidence of responsiveness to patient-reported change. Sequential evaluation in two independently recruited online samples, together with metric invariance across sex and age, supports the feasibility of structured psychometric validation using this type of recruitment. Its brief visual-analogue format and suitability for repeated administration make the CRIS particularly relevant to digital clinical settings, including longitudinal monitoring during CBT-I and digital CBT-I.
- Open Access
- 27 May 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e70193
Innovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development
Background: Chronic insomnia, or insomnia disorder, is a major health issue with a prevalence of up to 15%. The recommended first-line treatment is cognitive behavioral therapy for insomnia (CBT-i), which, unfortunately, remains insufficiently accessible. Digitalization has the potential to reduce health care access inequalities by offering more flexible and accessible care options. Digital CBT-i (dCBT-i) has been shown to be as effective as in-person CBT-i, highlighting its potential for broader implementation. Objective: This study aimed to develop an evidence-based dCBT-i program grounded in theoretical and clinical knowledge, designed for efficient integration into health care systems, and to establish it as the first prescribed digital treatment in France. Methods: The program was constructed based on validated CBT-i theory and practice, incorporating the latest scientific data on CBT for insomnia. It was designed as a robust multicomponent therapy, integrating an initial standardized assessment and daily intelligent adaptation to enable digital phenotyping and provide personalized treatment. Results: We developed an innovative digital solution that combines scientific rigor with practical application. The program includes a standardized initial evaluation and dynamic personalization through intelligent algorithms. These features allow for the adaptation of therapy based on patient progress and needs, ensuring individualized care. Conclusions: The development of this dCBT-i program represents a significant milestone in digital health care, offering a scalable solution to the accessibility challenges of traditional CBT-i. Future steps involve conducting clinical studies to further evaluate its effectiveness and optimize its implementation within health care systems.
- 27 May 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e70193
Open AccessInnovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development
Background: Chronic insomnia, or insomnia disorder, is a major health issue with a prevalence of up to 15%. The recommended first-line treatment is cognitive behavioral therapy for insomnia (CBT-i), which, unfortunately, remains insufficiently accessible. Digitalization has the potential to reduce health care access inequalities by offering more flexible and accessible care options. Digital CBT-i (dCBT-i) has been shown to be as effective as in-person CBT-i, highlighting its potential for broader implementation. Objective: This study aimed to develop an evidence-based dCBT-i program grounded in theoretical and clinical knowledge, designed for efficient integration into health care systems, and to establish it as the first prescribed digital treatment in France. Methods: The program was constructed based on validated CBT-i theory and practice, incorporating the latest scientific data on CBT for insomnia. It was designed as a robust multicomponent therapy, integrating an initial standardized assessment and daily intelligent adaptation to enable digital phenotyping and provide personalized treatment. Results: We developed an innovative digital solution that combines scientific rigor with practical application. The program includes a standardized initial evaluation and dynamic personalization through intelligent algorithms. These features allow for the adaptation of therapy based on patient progress and needs, ensuring individualized care. Conclusions: The development of this dCBT-i program represents a significant milestone in digital health care, offering a scalable solution to the accessibility challenges of traditional CBT-i. Future steps involve conducting clinical studies to further evaluate its effectiveness and optimize its implementation within health care systems.
- Open Access
- 17 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Innovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development (Preprint)
BACKGROUND Chronic insomnia, or insomnia disorder, is a major health issue with a prevalence of up to 15%. The recommended first-line treatment is cognitive behavioral therapy for insomnia (CBT-i), which, unfortunately, remains insufficiently accessible. Digitalization has the potential to reduce health care access inequalities by offering more flexible and accessible care options. Digital CBT-i (dCBT-i) has been shown to be as effective as in-person CBT-i, highlighting its potential for broader implementation. OBJECTIVE This study aimed to develop an evidence-based dCBT-i program grounded in theoretical and clinical knowledge, designed for efficient integration into health care systems, and to establish it as the first prescribed digital treatment in France. METHODS The program was constructed based on validated CBT-i theory and practice, incorporating the latest scientific data on CBT for insomnia. It was designed as a robust multicomponent therapy, integrating an initial standardized assessment and daily intelligent adaptation to enable digital phenotyping and provide personalized treatment. RESULTS We developed an innovative digital solution that combines scientific rigor with practical application. The program includes a standardized initial evaluation and dynamic personalization through intelligent algorithms. These features allow for the adaptation of therapy based on patient progress and needs, ensuring individualized care. CONCLUSIONS The development of this dCBT-i program represents a significant milestone in digital health care, offering a scalable solution to the accessibility challenges of traditional CBT-i. Future steps involve conducting clinical studies to further evaluate its effectiveness and optimize its implementation within health care systems.
- 17 December 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessInnovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development (Preprint)
BACKGROUND Chronic insomnia, or insomnia disorder, is a major health issue with a prevalence of up to 15%. The recommended first-line treatment is cognitive behavioral therapy for insomnia (CBT-i), which, unfortunately, remains insufficiently accessible. Digitalization has the potential to reduce health care access inequalities by offering more flexible and accessible care options. Digital CBT-i (dCBT-i) has been shown to be as effective as in-person CBT-i, highlighting its potential for broader implementation. OBJECTIVE This study aimed to develop an evidence-based dCBT-i program grounded in theoretical and clinical knowledge, designed for efficient integration into health care systems, and to establish it as the first prescribed digital treatment in France. METHODS The program was constructed based on validated CBT-i theory and practice, incorporating the latest scientific data on CBT for insomnia. It was designed as a robust multicomponent therapy, integrating an initial standardized assessment and daily intelligent adaptation to enable digital phenotyping and provide personalized treatment. RESULTS We developed an innovative digital solution that combines scientific rigor with practical application. The program includes a standardized initial evaluation and dynamic personalization through intelligent algorithms. These features allow for the adaptation of therapy based on patient progress and needs, ensuring individualized care. CONCLUSIONS The development of this dCBT-i program represents a significant milestone in digital health care, offering a scalable solution to the accessibility challenges of traditional CBT-i. Future steps involve conducting clinical studies to further evaluate its effectiveness and optimize its implementation within health care systems.